Plano-Based Integer Holdings Corp. (NYSE: ITGR)—one of the world’s leading medical device contract development and manufacturing organizations, with $1.59 billion in 2023 revenue—has doubled down on its longtime presence in the Emerald Isle.
Last week, Integer opened its new $30 million European medical device innovation and manufacturing center in Galway, Ireland. The 67,000-SF facility will support increasing demand for regional research, development, and manufacturing as well as additional capacity for catheters, medical textiles, and delivery systems, Integer said.
That followed the opening of a $60 million, 80,000-SF expansion of Integer’s guidewire manufacturing facility in New Ross, County Wexford, Ireland, earlier this month. (Guidewires are thin metal tubes used to guide catheters and other devices into place during minimally invasive medical procedures.)
That expansion increases manufacturing capacity at the New Ross site by more than 70%, Integer said, and includes new “state-of-the-art” manufacturing equipment to support customers’ long-term growth.
Integer said it continues to increase employment in Ireland, with more than 1,700 currently employed in the region.
Acquired Ireland’s Aran Biomedical in 2022
Joseph Dziedzic
The two facility openings come on the heels of Integer’s $140 million 2022 acquisition of Aran Biomedical, located in Spiddal, Ireland. A leader in proprietary medical textiles, high-precision biomaterial coverings and coatings, and advanced metal and polymer braiding, Aran develops and manufactures solutions for implantable medical devices.
“Our expansion in Ireland provides Integer with the capacity and differentiated capabilities to amplify our customers’ innovation and help them bring products to market faster,” Integer President and CEO Joseph Dziedzic said in a statement. “Integer’s significant investment in Ireland demonstrates our commitment to supporting our customers’ growth and furthers our unparalleled ability to be their partner of choice for developing the next generation of lifesaving and life-enhancing medical therapies.”
Integer has had eyes on Ireland since 1994
Integer has had its eyes on Ireland for three decades—while going through several transformations over the years, including acquisitions and mergers that have led to its current form and identity.
““Since Integer—then Lake Region Medical—first expanded into Ireland 30 years ago, our local team of talented professionals has partnered with leading medical device companies to develop and supply innovative, high-quality products to customers around the globe,” John Harris, EVP of global operations and manufacturing strategy at Integer, said in a statement.
“We’re excited about the expansion of our development and manufacturing network in Ireland and look forward to continued growth as we strengthen our ability to support our customers’ long-term strategy and technology needs, both in Ireland and globally,” Harris added.
More about Integer
Integer Holdings Corp. executives ring the bell at the New York Stock Exchange on May 22, 2024. [Photo: NYSE]
Integer serves the cardiac, vascular, rhythm management, and neuromodulation markets, with a goal of enhancing the lives of patients worldwide. The company’s brands include Greatbatch Medical, Lake Region Medical, and Electrochem. In addition, Integer develops batteries for high-end niche applications in energy, military, and environmental markets, the company said.
Last May, the company’s leadership team—including CEO Dziedzic and Board Chair Pamela Bailey—rang the opening bell at the New York Stock Exchange.
The company has also been ringing in new additions to its portfolio over the last year. In October 2023, Integer acquired Florida-based InNeuroCo, a leading founder-owned designer and contract manufacturer of “highly engineered, ultra-precise” neurovascular catheters.
Last January, Integer acquired Pennsylvania-based Pulse Technologies for $140 million. Pulse specializes in the micro-machining of components for structured heart, heart pump, cardiac electrophysiology, and related markets.
Integer is headquartered at Granite Park in Plano at 5830 Granite Parkway.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
MDIC is piloting the AMCH program, with support from the U.S. Food and Drug Administration, to help encourage the medical device industry to adopt advanced technology not just during device production but across the total product life cycle.
-
Ruediger Nigbur has been promoted to VP and general manager for Europe, the Middle East, and Africa, and Ray Bengermino has been appointed VP of U.S. sales. Their leadership comes at a pivotal time for AnX Robotica, said the company, which holds over 200 patents in advanced medical technology.
-
The Advanced Research Projects Agency for Health—or ARPA-H— wants to enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their homes. The agency officially launched its new Texas "customer experience" headquarters at Dallas' Pegasus Park on Thursday, which will be home base for the initiative.
-
UT Southwestern Medical Center and pharmaceutical company Pfizer have teamed up to develop new ways to deliver genetic treatments to patients. Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
-
Sleep helps cognitive function and emotional regulation, but a good night’s rest is hard to come by. The SM Wright Foundation is trying to address that problem through its Beds for Kids program, with the help of partners like Milton Sleep Company—a local manufacturer with a history of giving back.
